Co-Authors
This is a "connection" page, showing publications co-authored by Antonio Spanevello and Giovanni Sotgiu.
Connection Strength
1.786
-
The Role of Blood Gas Analysis in the Post-Acute Phase of COVID-19 Pneumonia. Arch Bronconeumol (Engl Ed). 2021 Jun 17.
Score: 0.238
-
Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med. 2000 Sep; 162(3 Pt 1):1172-4.
Score: 0.225
-
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae. Eur Respir J. 2019 03; 53(3).
Score: 0.203
-
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use. Clin Respir J. 2018 May; 12(5):1989-1990.
Score: 0.187
-
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence. Eur Respir J. 2013 Jul; 42(1):288-90.
Score: 0.137
-
Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. J Bras Pneumol. 2021; 47(4):e20210076.
Score: 0.060
-
Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients. Pulmonology. 2021 Sep-Oct; 27(5):452-455.
Score: 0.058
-
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid). Front Med (Lausanne). 2020; 7:572485.
Score: 0.057
-
Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J. 2020 10; 56(4).
Score: 0.057
-
Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020. Emerg Infect Dis. 2020 11; 26(11):2709-2712.
Score: 0.056
-
Tuberculosis in the time of COVID-19: quality of life and digital innovation. Eur Respir J. 2020 08; 56(2).
Score: 0.056
-
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020 07; 56(1).
Score: 0.056
-
Management and outcomes of post-acute COVID-19 patients in Northern Italy. Eur J Intern Med. 2020 08; 78:159-160.
Score: 0.055
-
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020 Jul - Aug; 26(4):233-240.
Score: 0.055
-
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis. J Asthma. 2020 12; 57(12):1365-1371.
Score: 0.052
-
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study. Respir Med. 2019 04; 150:95-100.
Score: 0.051
-
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review. Eur Respir J. 2018 07; 52(1).
Score: 0.048
-
Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management. Curr Opin Pulm Med. 2018 05; 24(3):244-252.
Score: 0.048
-
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J. 2017 05; 49(5).
Score: 0.045
-
Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis? J Bras Pneumol. 2016 Sep-Oct; 42(5):374-385.
Score: 0.043